title: Sexual dysfunction in cancer patients: a review.
abstract: Cancer is a life-threatening disease despite the advanced therapeutic strategies now available. A common problem is that physicians and patients tend to concentrate on intensive medical treatment options and underestimate the treatment-related adverse effects. In this review, we summarize one of these adverse effects in cancer patients; sexual dysfunction (SD). In addition, current therapeutic choices with optimal doses and patient selection strategies are defined. All patients should be informed about problems associated with therapy-related SD and must be guided toward the most appropriate therapeutic options before starting treatment.
authors.affiliation: Ege University Schhol of Medicine, Tulay Aktas Oncology Hospital, Bornova, Izmir, Turkey.
authors.forename: B
authors.initials: B
authors.lastname: Cakar
authors.forename: B
authors.initials: B
authors.lastname: Karaca
authors.forename: R
authors.initials: R
authors.lastname: Uslu
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D011832:Radiation Injuries / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D012725:Sexual Behavior / Q000187:drug effects / Q000528:radiation effects; D012735:Sexual Dysfunction, Physiological / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D020018:Sexual Dysfunctions, Psychological / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents